Sacyr, S.A.

BME:SCYR Lagerbericht

Marktkapitalisierung: €3.6b

Sacyr Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Sacyr wird ein jährliches Gewinn- und Umsatzwachstum von 17.8% bzw. 2.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 8.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.7% betragen.

Wichtige Informationen

17.8%

Wachstumsrate der Gewinne

8.61%

EPS-Wachstumsrate

Construction Gewinnwachstum9.7%
Wachstumsrate der Einnahmen2.3%
Zukünftige Eigenkapitalrendite14.72%
Analystenabdeckung

Good

Zuletzt aktualisiert30 Apr 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Analyseartikel Nov 10

Sacyr, S.A. (BME:SCYR) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Shareholders might have noticed that Sacyr, S.A. ( BME:SCYR ) filed its quarterly result this time last week. The early...
Analyseartikel Aug 01

Sacyr, S.A. (BME:SCYR) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Sacyr, S.A. ( BME:SCYR ) came out with its second-quarter results last week, and we wanted to see how the business is...

Recent updates

Analyseartikel Jan 03

Sacyr, S.A.'s (BME:SCYR) Business Is Trailing The Industry But Its Shares Aren't

It's not a stretch to say that Sacyr, S.A.'s ( BME:SCYR ) price-to-sales (or "P/S") ratio of 0.7x seems quite...
Analyseartikel Nov 10

Sacyr, S.A. (BME:SCYR) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Shareholders might have noticed that Sacyr, S.A. ( BME:SCYR ) filed its quarterly result this time last week. The early...
Analyseartikel Oct 19

Is Now An Opportune Moment To Examine Sacyr, S.A. (BME:SCYR)?

Sacyr, S.A. ( BME:SCYR ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...
Analyseartikel Aug 19

Is Sacyr (BME:SCYR) A Risky Investment?

BME:SCYR 1 Year Share Price vs Fair Value Explore Sacyr's Fair Values from the Community and select yours David Iben...
Analyseartikel Aug 01

Sacyr, S.A. (BME:SCYR) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Sacyr, S.A. ( BME:SCYR ) came out with its second-quarter results last week, and we wanted to see how the business is...
User avatar
Neues Narrativ Jul 19

Global Concession Wins Will Open Sustainable Markets

Strategic global concession wins and focus on sustainable infrastructure are expanding Sacyr's market presence and recurring, inflation-linked revenues.
Analyseartikel May 22

Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

It's not a stretch to say that Sacyr, S.A.'s ( BME:SCYR ) price-to-sales (or "P/S") ratio of 0.6x seems quite...
Analyseartikel Apr 01

Is Sacyr (BME:SCYR) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyseartikel Mar 12

Concerns Surrounding Sacyr's (BME:SCYR) Performance

Sacyr, S.A.'s ( BME:SCYR ) healthy profit numbers didn't contain any surprises for investors. We think this is due to...
Neues Narrativ Feb 24

Sacyr will reach €5.5 billion in revenues in 5 years

International Expansion: Sacyr's operations in over 20 countries, particularly in Latin America and southern Europe, contribute significantly to their revenue and backlog.
Analyseartikel Feb 08

Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

It's not a stretch to say that Sacyr, S.A.'s ( BME:SCYR ) price-to-sales (or "P/S") ratio of 0.5x seems quite...
Analyseartikel Dec 06

Is Sacyr (BME:SCYR) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel Sep 10

Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

There wouldn't be many who think Sacyr, S.A.'s ( BME:SCYR ) price-to-sales (or "P/S") ratio of 0.5x is worth a mention...
Analyseartikel Jun 06

Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

There wouldn't be many who think Sacyr, S.A.'s ( BME:SCYR ) price-to-sales (or "P/S") ratio of 0.5x is worth a mention...
Analyseartikel Apr 18

Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel Mar 06

Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

Sacyr, S.A. ( BME:SCYR ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Analyseartikel Sep 08

What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Sacyr, S.A. ( BME:SCYR ), might not be a large cap stock, but it saw significant share price movement during recent...
Analyseartikel Aug 18

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel May 11

Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Mar 22

Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

While Sacyr, S.A. ( BME:SCYR ) might not be the most widely known stock at the moment, it saw a decent share price...
Analyseartikel Feb 10

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analyseartikel Dec 01

Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

How far off is Sacyr, S.A. ( BME:SCYR ) from its intrinsic value? Using the most recent financial data, we'll take a...
Analyseartikel Nov 10

Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

It's been a good week for Sacyr, S.A. ( BME:SCYR ) shareholders, because the company has just released its latest...
Analyseartikel Aug 02

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel Jun 02

Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Sacyr, S.A. ( BME:SCYR ) has announced that it will be increasing its dividend on the 13th of June to €0.053. This will...
Analyseartikel Oct 19

Is Sacyr (BME:SCYR) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel Jul 14

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Mar 06

Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

Sacyr, S.A. ( BME:SCYR ) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders...
Analyseartikel Feb 19

An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Sacyr, S.A. ( BME:SCYR...
Analyseartikel Jan 20

How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

The big shareholder groups in Sacyr, S.A. ( BME:SCYR ) have power over the company. Large companies usually have...
Analyseartikel Dec 24

Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also...
Analyseartikel Dec 02

What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Over the last month the Sacyr, S.A. ( BME:SCYR ) has been much stronger than before, rebounding by 34%. But that...

Gewinn- und Umsatzwachstumsprognosen

BME:SCYR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20285,089195N/AN/A8
12/31/20274,950193N/AN/A10
12/31/20264,796166N/AN/A10
3/31/20264,72197N/AN/AN/A
12/31/20254,663861,1041,359N/A
9/30/20254,726102N/AN/AN/A
6/30/20254,694929921,335N/A
3/31/20254,640115N/AN/AN/A
12/31/20244,5761139611,294N/A
9/30/20244,639-157N/AN/AN/A
6/30/20244,569-1738311,061N/A
3/31/20244,565-156N/AN/AN/A
12/31/20234,621-158624848N/A
9/30/20235,647135N/AN/AN/A
6/30/20234,981122669806N/A
3/31/20235,956121N/AN/AN/A
12/31/20224,985102121705N/A
9/30/20225,478-182N/AN/AN/A
6/30/20224,706-183-45606N/A
3/31/20224,835-194N/AN/AN/A
12/31/20214,696-189428629N/A
9/30/20214,65549N/AN/AN/A
6/30/20214,6346478609N/A
3/31/20214,62029N/AN/AN/A
12/31/20204,54936410545N/A
9/30/20204,349-373N/AN/AN/A
6/30/20204,241-308377552N/A
3/31/20204,191-304N/AN/AN/A
12/31/20194,178-298N/A510N/A
9/30/20194,148164N/AN/AN/A
6/30/20194,031158N/A453N/A
3/31/20193,903154N/AN/AN/A
12/31/20183,818150N/A405N/A
9/30/20183,548143N/AN/AN/A
6/30/20183,375143N/A290N/A
3/31/20183,196134N/AN/AN/A
12/31/20173,094131N/A292N/A
9/30/20172,949127N/AN/AN/A
6/30/20172,970116N/A288N/A
3/31/20172,968109N/AN/AN/A
12/31/20162,862120N/A156N/A
9/30/20162,991-53N/AN/AN/A
6/30/20163,028-782N/A71N/A
3/31/20162,976-784N/AN/AN/A
12/31/20152,953-813N/A160N/A
9/30/20153,007-737N/AN/AN/A
6/30/20152,890-31N/A253N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SCYRDas prognostizierte Gewinnwachstum (17.8% pro Jahr) liegt über der Sparquote (2.7%).

Ertrag vs. Markt: SCYRDie Erträge des Unternehmens (17.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Spanish (11.6% pro Jahr).

Hohe Wachstumserträge: SCYRDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: SCYRDie Einnahmen des Unternehmens (2.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Spanish (6.3% pro Jahr).

Hohe Wachstumseinnahmen: SCYRDie Einnahmen des Unternehmens (2.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SCYRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.7%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/20 00:59
Aktienkurs zum Tagesende2026/05/20 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Sacyr, S.A. wird von 21 Analysten beobachtet. 10 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
null nullBanco de Sabadell. S.A.
Luis ArredondoBanco de Sabadell. S.A.
Joao Safara SilvaBanco Santander